Trials / Completed
CompletedNCT01552941
Safety and Efficacy Vagal Nerve Stimulation in Patients With Rheumatoid Arthritis
Pilot Study of the Safety and Efficacy of Neurostimulation of the Cholinergic Anti-Inflammatory Pathway Using an Active Implantable Vagal Nerve Stimulation Device in Patients With Rheumatoid Arthritis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- SetPoint Medical Corporation · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a 12 week open label pilot study to determine the efficacy and safety of a surgically implanted, electrically active vagal nerve stimulation device in patients with active rheumatoid arthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cyberonics VNS System | Active Implantable Electrical Vagal Nerve Stimulator |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2014-03-01
- Completion
- 2014-05-01
- First posted
- 2012-03-13
- Last updated
- 2016-11-01
Locations
4 sites across 3 countries: Bosnia and Herzegovina, Croatia, Netherlands
Source: ClinicalTrials.gov record NCT01552941. Inclusion in this directory is not an endorsement.